PRTA
Prothena Corporation plcNASDAQHealthcare$9.86-1.69%ClosedMarket Cap: $530.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.93
P/S
55.81
EV/EBITDA
-1.42
DCF Value
$3.35
FCF Yield
-31.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-208.6%
Operating Margin
-2247.5%
Net Margin
-2520.6%
ROE
-73.0%
ROA
-74.7%
ROIC
-75.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $21.0K | -4385.7% | $-27.2M | $-21.6M | $-0.40 | — |
| FY 2025 | $9.7M | 61.8% | $-184.6M | $-244.1M | $-4.53 | — |
| Q3 2025 | $2.4M | -1098.3% | $-40.2M | $-36.5M | $-0.68 | — |
| Q2 2025 | $4.4M | 100.0% | $-84.6M | $-125.8M | $-2.34 | — |
| Q1 2025 | $2.8M | 100.0% | $-65.6M | $-60.2M | $-1.12 | — |
| Q4 2024 | $2.1M | 100.0% | $-64.9M | $-58.0M | $-1.08 | — |
| FY 2024 | $135.2M | 100.0% | $-154.6M | $-122.3M | $-2.27 | — |
| Q3 2024 | $970.0K | 100.0% | $-66.5M | $-59.0M | $-1.10 | — |
| Q2 2024 | $132.0M | 100.0% | $58.4M | $66.9M | $1.22 | — |
| Q1 2024 | $50.0K | 100.0% | $-81.5M | $-72.2M | $-1.34 | — |
| Q4 2023 | $316.0K | -19485.8% | $-78.5M | $-67.5M | $-1.26 | — |
| FY 2023 | $91.4M | 100.0% | $-191.0M | $-147.0M | $-2.76 | — |